NCT00613899

Brief Summary

The investigators want to test feasibility of a structured program of telesurveillance and home cough assistance for ALS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Oct 2007

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2007

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

January 17, 2008

Completed
27 days until next milestone

First Posted

Study publicly available on registry

February 13, 2008

Completed
17 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2008

Completed
Last Updated

February 4, 2016

Status Verified

July 1, 2011

Enrollment Period

5 months

First QC Date

January 17, 2008

Last Update Submit

February 3, 2016

Conditions

Keywords

home carehome rehabilitationtelemedicineALS

Outcome Measures

Primary Outcomes (1)

  • To test a possible alternative of care for ALS patients (home vs hospital)

    6-12 months

Secondary Outcomes (1)

  • To check patients and caregivers' acceptance

    6-12 months

Study Arms (1)

Telesurveillance

OTHER

At time of discharge from hospital, 40 ALS patients willbe enrolled in a telesurveillance program (TP) for the management of cought at home. Two hours of an in-hospital educational training will be provided to patients and caregivers on the use of: 1. air stacking with Ambu balloon 2. manual manoeuvres and 3. in-Exoflator device indications and use

Other: telesurveillance

Interventions

A telesurveillance program for cough assistance will be approched by the use of an in-exoflator device. Measurement of oxygen saturation (SpO2) will be performed by a Nonin 9500 oxymeter (Minneapolis Plymouth USA).

Also known as: telemedicine
Telesurveillance

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ALS patients (VC \< 80% with or without tracheostomy)will be enrolled after discharge from Respiratory or Neurological units of S. Maugeri Foundation.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michele Vitacca

Lumezzane, BS, 25065, Italy

Location

Related Publications (3)

  • Sancho J, Servera E, Diaz J, Marin J. Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis. Chest. 2004 Apr;125(4):1400-5. doi: 10.1378/chest.125.4.1400.

    PMID: 15078752BACKGROUND
  • Vitacca M, Paneroni M, Trainini D, Bianchi L, Assoni G, Saleri M, Gile S, Winck JC, Goncalves MR. At home and on demand mechanical cough assistance program for patients with amyotrophic lateral sclerosis. Am J Phys Med Rehabil. 2010 May;89(5):401-6. doi: 10.1097/PHM.0b013e3181d89760.

  • Paneroni M, Trainini D, Winck JC, Vitacca M. Pilot study for home monitoring of cough capacity in amyotrophic lateral sclerosis: A case series. Rev Port Pneumol. 2014 Jul-Aug;20(4):181-7. doi: 10.1016/j.rppneu.2013.11.003. Epub 2014 Feb 1.

Related Links

MeSH Terms

Conditions

Amyotrophic Lateral Sclerosis

Interventions

Telemedicine

Condition Hierarchy (Ancestors)

Spinal Cord DiseasesCentral Nervous System DiseasesNervous System DiseasesMotor Neuron DiseaseNeurodegenerative DiseasesTDP-43 ProteinopathiesNeuromuscular DiseasesProteostasis DeficienciesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Delivery of Health CarePatient Care ManagementHealth Services Administration

Study Officials

  • michele vitacca, MD

    FSM IRCCS Lumezzane

    STUDY CHAIR
  • michele vitacca, MD

    FSM IRCCS LUmezzane (BS) ITALY

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

January 17, 2008

First Posted

February 13, 2008

Study Start

October 1, 2007

Primary Completion

March 1, 2008

Study Completion

October 1, 2008

Last Updated

February 4, 2016

Record last verified: 2011-07

Locations